Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 23569309

Phase III, multicenter, randomized trial of maintenance chemotherapy versus observation in patients with metastatic breast cancer after achieving disease control with six cycles of gemcitabine plus paclitaxel as first-line chemotherapy: KCSG-BR07-02.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2013 May 10
First author
Park YH

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2013 May 10;31(14):1707-8. doi: 10.1200/JCO.2013.48.6894.
    note
    Source null
    related pmid
    23569322
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2013 Jul;10(7):370-2. doi: 10.1038/nrclinonc.2013.87.
    note
    Source null
    related pmid
    23712182
    relationship
    Comment in

Authors and identifiers

  1. name
    Park YH
    type
    Author
  2. name
    Jung KH
    type
    Author
  3. name
    Im SA
    type
    Author
  4. name
    Sohn JH
    type
    Author
  5. name
    Ro J
    type
    Author
  6. name
    Ahn JH
    type
    Author
  7. name
    Kim SB
    type
    Author
  8. name
    Nam BH
    type
    Author
  9. name
    Oh DY
    type
    Author
  10. name
    Han SW
    type
    Author
  11. name
    Lee S
    type
    Author
  12. name
    Park IH
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Park YH
    type
    Author
  2. name
    Jung KH
    type
    Author
  3. name
    Im SA
    type
    Author
  4. name
    Sohn JH
    type
    Author
  5. name
    Ro J
    type
    Author
  6. name
    Ahn JH
    type
    Author
  7. name
    Kim SB
    type
    Author
  8. name
    Nam BH
    type
    Author
  9. name
    Oh DY
    type
    Author
  10. name
    Han SW
    type
    Author
  11. name
    Lee S
    type
    Author
  12. name
    Park IH
    type
    Author
bibliography ids
  1. nci-bib-df8c79ffab7c9c941cd286f8
book metadata
content sha256
2e3e2cf0df79c1281eac55fcc851ac839c66cadf0e1348d32cebe05f752cdb1d
document type
citation
dois
  1. 10.1200/JCO.2012.45.2490
electronic publication date
display
2013 Apr 8
precision
day
year
2013
evidence scope
bibliographic_metadata_only
id
pubmed:23569309
immutable id
pubmed:23569309@2e3e2cf0df79c1281eac55fcc851ac839c66cadf0e1348d32cebe05f752cdb1d
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
14
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
1732-9
volume
31
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2013 May 10;31(14):1707-8. doi: 10.1200/JCO.2013.48.6894.
    note
    Source null
    related pmid
    23569322
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2013 Jul;10(7):370-2. doi: 10.1038/nrclinonc.2013.87.
    note
    Source null
    related pmid
    23712182
    relationship
    Comment in
outcomes validated
false
pmid
23569309
provenance
batch id
99e008dabc339d38fd44
provider
NCBI PubMed ESummary
record sha256
b9e78e1831b9571b326c5927e26d1ec9732f35c99c448ea0aa545852cc8b16b8
response sha256
804916232567480946eda9a00aff276bc44fd9a6d15d9336e773a9c803123d39
retrieved at
2026-09-09T23:46:55.094762+00:00
publication date
display
2013 May 10
precision
day
year
2013
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/23569309/
title
Phase III, multicenter, randomized trial of maintenance chemotherapy versus observation in patients with metastatic breast cancer after achieving disease control with six cycles of gemcitabine plus paclitaxel as first-line chemotherapy: KCSG-BR07-02.

Preserved source evidence · Not medical advice